What is the appropriate management for a female patient presenting to the emergency department with chest pain and an intermediate‑risk (score 4) for major adverse cardiac events?

Management of Intermediate-Risk Chest Pain (HEART Score 4)

For a female patient with chest pain and a HEART score of 4, admit to an observation unit for serial troponin testing at 3–6 hours, continuous cardiac monitoring, and pre-discharge noninvasive stress testing or coronary CT angiography—followed by outpatient cardiology follow-up within 7 days if testing is normal. 1

Immediate Risk Stratification Context

• A HEART score of 4 places this patient in the intermediate-risk category, which carries a significantly higher 30-day major adverse cardiac event (MACE) rate than low-risk patients but does not mandate immediate invasive coronary angiography unless high-risk features emerge. 1, 2, 3
• Intermediate-risk patients (HEART 4–6) have approximately 12–20% risk of 30-day MACE, compared to <2% for low-risk (HEART ≤3) and >50% for high-risk (HEART ≥7) patients. 2, 3
• The 2022 ACC Expert Consensus Decision Pathway explicitly addresses this population, noting they frequently have pre-existing cardiovascular disease, multiple risk factors, and medical comorbidities requiring close follow-up. 1

Observation Unit Protocol

• Admit to a chest pain observation unit rather than full inpatient admission, which provides cost-effective monitoring while maintaining safety. 1, 4
• Obtain serial high-sensitivity troponin at 3–6 hours after the initial draw (or 1–3 hours if high-sensitivity assay is available), because a single normal troponin does not exclude acute coronary syndrome. 1, 5
• Continuous cardiac monitoring with defibrillation capability is mandatory throughout the observation period to detect arrhythmias. 1, 5
• The observation period typically lasts 10–12 hours for intermediate-risk patients. 1, 5

Pre-Discharge Noninvasive Testing Strategy

• If serial troponins remain negative and ECG shows no ischemic changes, proceed with pre-discharge noninvasive testing to definitively exclude obstructive coronary artery disease. 1, 5
• Stress testing options include exercise ECG, stress echocardiography, or stress myocardial perfusion imaging, depending on the patient's ability to exercise and baseline ECG interpretability. 1, 5
• Coronary CT angiography is an alternative to functional stress testing and may be preferred in younger patients or those with low-to-intermediate pre-test probability. 1, 5
• Patients with normal or low-risk stress test results can be safely discharged with outpatient cardiology follow-up. 1
• Patients with moderate or severe ischemia on stress testing or obstructive CAD (≥70% stenosis) on CT angiography should be admitted for further evaluation and strong consideration for invasive coronary angiography. 1

Disposition Based on Testing Results

Normal/Low-Risk Testing

• Discharge home with cardiology follow-up within 7 days (preferably with the patient's established cardiologist or primary care physician). 1
• Initiate preventive medical therapy including aspirin, statin, and blood pressure control as appropriate. 1
• Provide explicit return precautions: instruct the patient to call 911 for recurrent chest pain that differs from the index presentation, is more severe, lasts >20 minutes, or is accompanied by diaphoresis, dyspnea, or radiation to the arm/jaw. 1, 5

Abnormal Testing

• Admit to inpatient cardiology service for patients with moderate-to-severe ischemia, obstructive CAD, or borderline findings requiring further risk stratification. 1
• Arrange urgent coronary angiography for patients with high-risk stress test features (extensive ischemia, reduced left ventricular function, or hemodynamic instability during testing). 1

Special Considerations for Women

• Women are at higher risk for underdiagnosis of acute coronary syndrome because they more frequently present with atypical symptoms (jaw/neck pain, nausea, fatigue, dyspnea, epigastric discomfort) rather than classic chest pressure. 1, 5
• Use sex-specific high-sensitivity troponin thresholds (>16 ng/L for women vs >34 ng/L for men), as universal cut-offs miss approximately 30% of women with myocardial injury. 5
• Actively inquire about accompanying symptoms during history-taking, as women report three or more accompanying symptoms more frequently than men during acute coronary syndrome. 5

Alternative Discharge Strategy (Emerging Evidence)

• Recent single-center data suggest that intermediate-risk HEART score patients (score 4–6) may be safely discharged directly from the ED with rapid outpatient cardiology follow-up within 2 business days, avoiding observation unit admission entirely. 6
• In this cohort of 333 patients, only 1 death (0.3%) occurred within 30 days, with no myocardial infarctions, and 79% of patients kept their follow-up appointment. 6
• This strategy requires a formalized process for rapid cardiology follow-up and shared decision-making with the patient regarding the risks and benefits of early discharge versus observation unit admission. 6
• However, the 2022 ACC guideline does not yet endorse this approach as standard practice, and observation unit admission with pre-discharge testing remains the recommended pathway. 1

Critical Pitfalls to Avoid

• Do not discharge intermediate-risk patients without objective cardiac testing (either serial troponins plus stress testing, or rapid outpatient cardiology follow-up with a formalized protocol). 1, 6
• Do not assume a normal initial ECG and troponin exclude acute coronary syndrome; 30–40% of acute myocardial infarctions present with a normal or nondiagnostic initial ECG. 1, 5
• Do not rely on nitroglycerin response to differentiate cardiac from non-cardiac chest pain, as esophageal spasm and other conditions may also improve. 1, 5
• Avoid the term "atypical chest pain" in documentation; instead describe presentations as "cardiac," "possibly cardiac," or "non-cardiac" to prevent misinterpretation as benign. 1, 5
• Do not delay follow-up beyond 7 days for intermediate-risk patients, as they have a substantially higher event rate than low-risk patients and require close monitoring. 1

Summary Algorithm

1. Confirm HEART score 4 with serial troponin and repeat ECG if initial testing is nondiagnostic. 1, 5
2. Admit to observation unit for 10–12 hours with continuous monitoring. 1, 5
3. Obtain serial troponin at 3–6 hours; if negative, proceed to pre-discharge stress testing or coronary CT angiography. 1, 5
4. If testing is normal/low-risk, discharge with cardiology follow-up within 7 days and initiate preventive therapies. 1
5. If testing shows moderate-to-severe ischemia or obstructive CAD, admit for inpatient evaluation and consider invasive coronary angiography. 1